Health-related quality of life and psychological states in patients with pulmonary arterial hypertension

Journal of Cardiovascular Nursing

Volumn 29, Issue 2, 2014, Pages 178-184

  Matura, Lea Ann ^a   McDonough, Annette ^b   Carroll, Diane L ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; AFFECT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH STATUS INDICATOR; HUMAN; MALE; MENTAL HEALTH; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PULMONARY HYPERTENSION; QUALITY OF LIFE;

ADAPTATION, PSYCHOLOGICAL; AFFECT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; HYPERTENSION, PULMONARY; MALE; MENTAL HEALTH; MIDDLE AGED; QUALITY OF LIFE;

EID: 84894094628     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e318275330d     Document Type: Article

References (43)

1. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(Suppl 1):S43-S54.
2. CDC. Pulmonary hypertension surveillanceVUnited States, 1980-2002. MMWR Surveill Summ. 2005;54:1-28.
3. Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30(1):104-109. (Pubitemid 47074013)
4. HumbertM, SitbonO, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173(9):1023-1030.
5. Brown LM, Chen H, Halpern S, et al. Delay in recognition of pulmonary arterial hypertension. Chest. 2011;140(1):19-26.
6. Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J. 2010;35(5):1079-1087.
7. Badesch DB, McLaughlin VV, Delcroix M, et al. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(Suppl 12):S56-S61.
8. Oudiz RJ, Farber HW. Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: an experience-based review. Am Heart J. 2009;157(4): 625-635.
9. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009;30(20):2493-2537.
10. Matura LA, Carroll DL. Human responses to pulmonary arterial hypertension: review of the literature. J Cardiovasc Nurs. 2010;25(5):420-427.
11. Flattery M, Pinson J, Savage L, Salyer J. Living with pulmonary artery hypertension: patients' experiences. Heart Lung. 2005;34(2):99-107. (Pubitemid 40343085)
12. Chen H, Taichman DB, Doyle RL. Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension. Proc Am Thorac Soc. 2008;5(5):623-630. (Pubitemid 352031535)
13. Revicki D, Gnanasakthy A, Weinfurt K. Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier. Qual Life Res. 2007;16(4):717-723. (Pubitemid 46474951)
14. Rubenfire M, Lippo G, Bodini BD, Blasi F, Allegra L, Bossone E. Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension. Chest. 2009;136(2):597-603.
15. Shafazand S, Goldstein MK, Doyle RL, Hlatky MA, Gould MK. Health-related quality of life in patients with pulmonary arterial hypertension. Chest. 2004;126(5):1452-1459. (Pubitemid 39525016)
16. Taichman D, Shin J, Hud L, et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res. 2005;6(1):92.
17. Zlupko M, Harhay MO, Gallop R, et al. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir Med. 2008;102(10): 1431-1438.
18. White J,Hopkins R, Glissmeyer E, KittermanN, Elliott CG. Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res. 2006;7(1):55.
19. Matura L, McDonough A, Carroll D. Predictors of healthrelated quality of life in patients with idiopathic pulmonary arterial hypertension. J Hosp Palliat Nurs. 2012;14(4): 283-292. doi: 210.1097/NJH.1090b1013e3182496c3182404.
20. Lowe B, Grafe K, Ufer C, et al. Anxiety and depression in patients with pulmonary hypertension. Psychosom Med. 2004;66(6):831-836. (Pubitemid 39552865)
21. Looper K, Pierre A, Dunkley D, Sigal J, Langleben D. Depressive symptoms in relation to physical functioning in pulmonary hypertension. J Psychosom Res. 2009;66(3):221-225.
22. McCollister DH, Beutz M, McLaughlin V, et al. Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status. Psychosomatics. 2010;51(4):339-3398.
23. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160- 164.
24. McKenna S,DoughtyN,Meads D, Doward L, Pepke-Zaba J. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res. 2006;15(1):103-115. (Pubitemid 43097591)
25. Gomberg-Maitland M, Thenappan T, Rizvi K, Chandra S, MeadsD,McKenna S. United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR). J Heart Lung Transplant. 2008;27(1):124-130.
26. McNair DM, Lorr M, Droppleman LF, McNair DM, Lorr M, Droppleman LF. Profile of Mood StatesVBrief. North Tonawanda, NY: MHS/Multi-Health Systems; 2009.
27. Statistical Package for the Social Sciences (SPSS) [computer program]. Version 18. Somers, NY: SPSS, Inc; 2010.
28. Chua R, Keogh A, Byth K, O'Loughlin A. Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. Intern Med J. 2006;36(11):705-710. (Pubitemid 44563431)
29. Chow S, Pope J,Mehta S. Lack of correlation of the health assessment questionnaire disability index with lung parameters in systemic sclerosis associated pulmonary arterial hypertension. Clin Exp Rheumatol. 2008;26(6):1012-1017.
30. Ware JE Jr., Sherbourne CD, Achat H, et al. MOS 36-item Short-Form Health Survey: optimism and depression as predictors of physical and mental health functioning: the Normative Aging Study. Ann Behav Med. 2000;22(2):127-130. (Pubitemid 32429377)
31. Ware JE, KosinskiM,Dewey JE. How to Score Version Two of the SF-36 Health Survey. 3rd ed. Lincoln, RI: Quality Metric Incorporated; 2000.
32. Schulz U, Pischke CR, Weidner G, et al. Social support group attendance is related to blood pressure, health behaviours, and quality of life in the Multicenter Lifestyle Demonstration Project. Psychol Health Med. 2008;13(4):423-437.
33. Cenedese E, Speich R, Dorschner L, et al. Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J. 2006;28(4):808-815. (Pubitemid 46332003)
34. Juenger J, Schellberg D, Kraemer S, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002;87(3):235-241. (Pubitemid 34177677)
35. Paskulin L, Vianna L, Molzahn AE. Factors associated with quality of life of Brazilian older adults. Int Nurs Rev. 2009;56(1):109-115.
36. Patti F, Pozzilli C, Montanari E, et al. Effects of education level and employment status on HRQoL in early relapsingremitting multiple sclerosis. Mult Scler. 2007;13(6):783-791. (Pubitemid 47074103)
37. Cullen D, Stiffler D. Long-term oxygen therapy: review from the patients' perspective. Chron Respir Dis. 2009;6(3): 141-147.
38. McDonough A, Matura L, Carroll D. Symptom experience of pulmonary arterial hypertension patients. Clin Nurs Res. 2011;20(2):120-134.
39. Hopp FP, Thornton N, Martin L. The lived experience of heart failure at the end of life: a systematic literature review. Health Soc Work. 2010;35(2):109-117.
40. Park CL, Malone MR, Suresh DP, Bliss D, Rosen RI. Coping, meaning in life, and quality of life in congestive heart failure patients. Qual Life Res. 2008;17(1):21-26.
41. Nyenhuis DL, Yamamoto C, Luchetta T, Terrien A, Parmentier A. Adult and geriatric normative data and validation of the Profile of Mood States. J Clin Psychol. 1999; 55(1):79-86. (Pubitemid 29044742)
42. Matura L, McDonough A, Carroll D. Cluster analysis of symptoms in pulmonary arterial hypertension: a pilot study. Eur J Cardiovasc Nurs. 2012;11(1):51-61.
43. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137(2):376-387.